DOI:
10.1055/s-00034924
Nuklearmedizin - NuclearMedicine
LinksClose Window
References
Werner RA, Beykan S, Higuchi T. et al.
The impact of 177Lu-octreotide therapy on 99mTc-MAG3 clearance is not predictive for late nephropathy.
Oncotarget 2016;
7: 41233-41241 . doi:10.18632/oncotarget.9775
Access:
We do not assume any responsibility for the contents of the web pages of other providers.